These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21505715)

  • 21. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
    Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
    Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery.
    Mehta RH; Roe MT; Mulgund J; Ohman EM; Cannon CP; Gibler WB; Pollack CV; Smith SC; Ferguson TB; Peterson ED
    J Am Coll Cardiol; 2006 Jul; 48(2):281-6. PubMed ID: 16843176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization.
    Gao P; Xiong H; Zheng Z; Li L; Gao R; Hu SS
    Platelets; 2010; 21(3):183-90. PubMed ID: 20201634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of a waiting period after clopidogrel treatment before performing coronary artery bypass grafting.
    Reichert MG; Robinson AH; Travis JA; Hammon JW; Kon ND; Kincaid EH
    Pharmacotherapy; 2008 Feb; 28(2):151-5. PubMed ID: 18225962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unmet needs in oral antiplatelet therapy with ADP receptor blocking agents.
    Husted S
    Fundam Clin Pharmacol; 2009 Feb; 23(1):1-9. PubMed ID: 19267766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bleeding risk with AZD6140, a reversible P2Y12 receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial.
    Husted S; Harrington RA; Cannon CP; Storey RF; Mitchell P; Emanuelsson H
    Int J Clin Pract; 2009 Apr; 63(4):667-70. PubMed ID: 19335707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet function testing to time surgery in patients on dual antiplatelet therapy?
    Mahla E; Raggam R; Toller W
    Hamostaseologie; 2014; 34(1):40-5. PubMed ID: 24071994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Latest clinical data on testing for high on-treatment platelet reactivity.
    Fileti L; Campo G; Valgimigli M
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S14-22. PubMed ID: 22080983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controversies in oral antiplatelet therapy in patients undergoing aortocoronary bypass surgery.
    Mahla E; Metzler H; Tantry US; Gurbel PA
    Ann Thorac Surg; 2010 Sep; 90(3):1040-51. PubMed ID: 20732553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP.
    Moerenhout CM; Claeys MJ; Haine S; Miljoen H; Bosmans JM; Vertessen F; Kluppels K; Van der Planken M; Vrints CJ
    Am Heart J; 2010 Mar; 159(3):434-8. PubMed ID: 20211306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative platelet inhibition with ASA does not influence postoperative blood loss following coronary artery bypass grafting.
    Gulbins H; Malkoc A; Ennker IC; Ennker J
    Thorac Cardiovasc Surg; 2009 Feb; 57(1):18-21. PubMed ID: 19169991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.
    Ballotta A; Saleh HZ; El Baghdady HW; Gomaa M; Belloli F; Kandil H; Balbaa Y; Bettini F; Bossone E; Menicanti L; Frigiola A; Bellucci C; Mehta RH
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):132-8. PubMed ID: 17599498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.
    Burke MA; Lee R; Fintel DJ
    Am Heart J; 2011 May; 161(5):832-41. PubMed ID: 21570511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
    Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
    Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients.
    Paniccia R; Antonucci E; Maggini N; Miranda M; Gori AM; Marcucci R; Giusti B; Balzi D; Prisco D; Abbate R
    Thromb Haemost; 2010 Aug; 104(2):287-92. PubMed ID: 20458439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel treatment before coronary artery bypass graft surgery increases postoperative morbidity and blood product requirements.
    Filsoufi F; Rahmanian PB; Castillo JG; Kahn RA; Fischer G; Adams DH
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):60-6. PubMed ID: 18249332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
    Bonello L; Tantry US; Marcucci R; Blindt R; Angiolillo DJ; Becker R; Bhatt DL; Cattaneo M; Collet JP; Cuisset T; Gachet C; Montalescot G; Jennings LK; Kereiakes D; Sibbing D; Trenk D; Van Werkum JW; Paganelli F; Price MJ; Waksman R; Gurbel PA;
    J Am Coll Cardiol; 2010 Sep; 56(12):919-33. PubMed ID: 20828644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
    Jennings LK
    Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
    Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
    Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.